Swiss NanoConvention Lectures

Thomas Hartung: Toxicicology for the 21st Century – an Opportunity for Nanotoxicology (2011)

Nanomaterials are acclaimed for their novel properties. But as properties change, unwanted properties are to be expected as well. Thomas Hartung explains how the innumerous formulations of nanomaterials will change toxicity assessments, including the development of alternatives to animal testing.

Tomas Borer: Die Schweiz im Vergleich: Mega-Standort für Nano-Wirtschaft? (2011)

Die Schweiz steht in Forschung und Entwicklung nanotechnologischer Produkte und Verfahren im internationalen Wettbewerb. Tomas Borers Analyse der aktuellen wirtschaftlichen Situation zeigt ein erfreuliches Bild, offenbart jedoch auch Entwicklungschancen, die es zu nutzen gilt.

Hervé This : How to envision billions of nanosystems? Considering cuisine is helpful (2011)

Most food consists of colloidal systems, such as so-called formulated products, i.e. cosmetics, drugs, coatings. For the description of such systems, a formalism was introduced. Hervé This explains, how it was increased for the description of both colloidal systems and the non-periodical organization of such systems.

Julianna Lisziewicz: Boosting the Immune System with DermaVir Nanomedicine: Can it Change the Treatment Paradigm of HIV? (2011)

The human immune system is well prepared to fight diseases. In people with chronic diseases like HIV infection, however, the immune system cannot win. The next breakthrough in treating chronic infections is expected to come from immune boosting medicines. Julianna Lisziewicz explains how nanotechnology has enabled the development of an immune therapy for HIV/AIDS.

Aymeric Sallin: Investing in Nanotechnology (2011)

Due to its ability to enable materials, devices and systems with new properties and functions, nanotechnology is viewed as «the next industrial revolution». Aymeric Sallin explains how investors find the most promising nanotech start-ups and transform the companies into profitable businesses.